pirfenidone has been researched along with Silicosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, C; Jia, Q; Li, M; Tang, Q; Xing, C; Zhang, Z | 1 |
| Bo, C; Guo, J; Jia, Q; Shao, H; Yang, Z; Zhang, Z | 1 |
2 other study(ies) available for pirfenidone and Silicosis
| Article | Year |
|---|---|
Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways.
Topics: Animals; Fibrosis; Hydroxyproline; Interleukin-18; Janus Kinase 2; Macrophages; Pneumonia; Pulmonary Fibrosis; Pyridones; Rats; RNA, Messenger; Signal Transduction; Silicosis; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vimentin | 2022 |
Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model.
Topics: Animals; Epithelial-Mesenchymal Transition; Male; Models, Animal; Pulmonary Fibrosis; Pyridones; Rats; Silicon Dioxide; Silicosis | 2019 |